Comparative Pharmacology
Head-to-head clinical analysis: ASCORBIC ACID versus HEXA BETALIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ASCORBIC ACID versus HEXA BETALIN.
ASCORBIC ACID vs HEXA-BETALIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ascorbic acid is a water-soluble vitamin that acts as an electron donor for several enzymatic reactions, including collagen synthesis, neurotransmitter synthesis, and carnitine synthesis. It also functions as a potent antioxidant, protecting cells from oxidative damage.
Hexa-Betalin is a combination of six B vitamins (B1, B2, B3, B5, B6, B12) that act as cofactors in various enzymatic reactions involved in energy metabolism, neurotransmitter synthesis, and nerve function.
Oral: 100-200 mg daily for prevention; 500-1000 mg daily for deficiency. IV/IM: 100-250 mg once daily for deficiency; higher doses (e.g., 1-3 g daily) for scurvy.
Dosage forms: Tablet 10mg, 50mg, 100mg, 250mg; Injection 50mg/mL. Usual adult dose: 100–250mg orally 1–3 times daily. Maximum 1000mg/day. IV/IM: 50–250mg every 6–8 hours as needed.
None Documented
None Documented
Clinical Note
moderateAscorbic acid + Cyclosporine
"The serum concentration of Cyclosporine can be decreased when it is combined with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Bortezomib
"The therapeutic efficacy of Bortezomib can be decreased when used in combination with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Benzphetamine
"The serum concentration of Benzphetamine can be decreased when it is combined with Ascorbic acid."
Clinical Note
moderateAscorbic acid + Amphetamine
Terminal half-life: 10-20 hours in healthy adults; prolonged in renal impairment. Clinical context: doses >200 mg/day lead to renal elimination of unchanged ascorbate, reducing half-life.
Terminal elimination half-life is approximately 3-5 hours in patients with normal renal function. This short half-life necessitates frequent dosing for sustained therapeutic effect. Half-life is prolonged in renal impairment.
Renal: 100% as unchanged drug and metabolites; tubular reabsorption is saturable; at high doses, excretion increases proportionally. Fecal: minimal.
Renal excretion of unchanged drug accounts for 75-85% of the administered dose. Biliary/fecal elimination is minimal, less than 5%.
Category C
Category C
Vitamin
Vitamin
"The serum concentration of Amphetamine can be decreased when it is combined with Ascorbic acid."